Basic information
- CAS
29110-47-2- Standard SMILES
Cl.NC(N)=NC(=O)Cc1c(Cl)cccc1Cl- InChIKey
DGFYECXYGUIODH-UHFFFAOYSA-N- Molecular formula
- C9H10Cl3N3O
- Average molar mass
- 282.5 g/mol
- Monoisotopic mass
- 280.988945
Overview
Guanfacine hydrochloride is a member of acetamides. It has a role as a geroprotector.
Names & identifiers
- Preferred name
- Guanfacine Hydrochloride
- IUPAC
- N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride
- English name
- Guanfacine
- Molecular formula
- C9H9Cl2N3O
- Molecular weight
- 246.09
Names & synonyms
guanfacine hydrochloride29110-48-3GUANFACINE HCLIntunivBS 100-141SPD503N-(Aminoiminomethyl)-2,6-dichlorobenzeneacetamide hydrochlorideGuafacine hydrochlorideDTXSID2045157BS-100-141PML56A160OBenzeneacetamide, N-(aminoiminomethyl)-2,6-dichloro-, monohydrochloride
Show more names
C07037SPD 503SPD-503GuanfacineGuanfacine USP/EP/BPGuanfacine free baseGuanfacine Solution, 100ppm[(2,6-Dichlorophenyl)acetyl]guanidine2-(2,6-Dichlorophenylacetyl)guanidine
DTXCID0025157GaunfacineAkfenGuanfacine ERRefChem:58777Hydrochloride, GuanfacineGuanfacine Extended-releaseGuanfacine Monohydrochloride
Database identifiers
- CAS
29110-47-2、29110-48-3- PubChem CID
- 71401
Properties
Computed structural properties
- Topological polar surface area
- 81.5 Ų
- Hydrogen bond donors
- 3
- Hydrogen bond acceptors
- 1
- Rotatable bonds
- 2
- Heavy atoms
- 16
- Formal charge
- 0
- Complexity
- 256
Experimental & physicochemical properties
Human Drugs
Breast Feeding; Lactation; Milk, Human; Antihypertensive Agents; Adrenergic alpha-2 Receptor Agonists
FDA approved drugs -> Active ingredient
EMA approved medicines: Human medicine
EMA approved medicines: Human medicine
FDA approved drugs -> Active ingredient
Ionization Efficiency
Positive
3.65
2.7
Agilent XCT
Electrospray ionization
formic acid (5.3nM)
Physicochemical properties
- Melting point
- 227 · 227-230C
- Density
- 1.5 · 1.50±0.1 g/cm3(Predicted)
- storage temp.
- Refrigerator
- solubility
- Soluble in DMSO
- form
- Powder
- pka
- 11.92 · 11.92±0.46(Predicted)
- color
- White to off-white
- BCS Class
- 1 · 1
- EWG's Food Scores
- 1 · 1
Safety & regulation
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
GHS classification
GHS Classification
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 63 reports by companies from 3 notifications to the ECHA C&L Inventory.
Hazard information
Hazard Classes and CategoriesAcute Tox. 3 (100%)
Toxicology
Drug Induced Liver Injury
Drug Induced Liver Injury Rank (DILIrank 2.0)
Guanfacine hydrochloride
Ambiguous-DILI-concern
3
Adverse reactions
DOI:10.1016/j.drudis.2016.02.015
Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Safety data
- Signal word
- Danger
- Symbol(GHS)
- GHS06
- Hazard statements
- H301
- Precautionary statements
- P264-P270-P301+P310-P321-P330-P405-P501
Chemistry & industry
Pharmacology
FDA Pharmacological Classification
GUANFACINE ER
Central alpha-2 Adrenergic Agonist [EPC]; Adrenergic alpha2-Agonists [MoA]
GUANFACINE HYDROCHLORIDE
Central alpha-2 Adrenergic Agonist [EPC]; Adrenergic alpha2-Agonists [MoA]
GAUNFACINE
Central alpha-2 Adrenergic Agonist [EPC]; Adrenergic alpha2-Agonists [MoA]
MeSH Pharmacological Classification
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Compounds that bind to and activate ADRENERGIC ALPHA-2 RECEPTORS.
Applications
UsesCentrally acting α-adrenoceptor agonist. Antihypertensive.
UsesGuanfacine centrally acting α-adrenoceptor agonist. Guanfacine is an antihypertensive.
General DescriptionGuanfacine is more selective for 2-receptors than isclonidine. Their mechanism of action is the same as that ofclonidine. Differences between clonidine and its twoanalogs are seen in their elimination half-life values and intheir metabolism and urinary excretion patterns. The eliminationhalf-life of clonidine ranges from 20 to 25 hours,whereas that for guanfacine is about 17 hours. Guanabenzhas the shortest DOA of these three agents, with a half-lifeof about 6 hours. Clonidine and guanfacine are excretedunchanged in the urine to the extent of 60% and 50%,respectively. Very little of guanabenz is excreted unchangedin the urine.
Upstream & downstream products
Upstream raw materials
Related reactions
0 records
No reaction records under the current filter.
Compound notes
Loading…